Scott B. Seaman
President bij ICT Holdings LLC
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| David Shanahan | M | - |
Gradalis, Inc.
 Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
| John Nemunaitis | M | - |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
| Steven Engle | M | 69 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | 2 jaar |
| Harry R. Jacobson | M | 76 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
| Robert P. Landin | M | 54 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
| Ernest Bognar | M | - |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | 9 jaar |
| Joseph Cunningham | M | - |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
| JF Berry | M | - |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Neil Warma | M | 61 |
Opexa Therapeutics, Inc.
 Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 9 jaar |
| Lynne Hohlfeld | F | 64 |
PharmaFrontiers Corp.
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 jaar |
| Michael Richman | M | 63 |
PharmaFrontiers Corp.
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 11 jaar |
| Sandy Livney | F | - |
PharmaFrontiers Corp.
| - |
| Jaye L. Thompson | M | 58 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 4 jaar |
| C. William Rouse | M | - |
PharmaFrontiers Corp.
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | - |
| Gregory Bailey | M | 68 |
PharmaFrontiers Corp.
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 2 jaar |
| Gail Maderis | F | 66 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 6 jaar |
| Jim C. Williams | M | 80 |
PharmaFrontiers Corp.
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 5 jaar |
| Kenny S. Frazier | M | - |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | - |
| Timothy Barabe | M | 71 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 jaar |
| Joseph Limber | M | 71 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | 2 jaar |
| David Jorden | M | 61 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 5 jaar |
| David Hung | M | 66 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 5 jaar |
| Hans-Peter Hartung | M | - |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 jaar |
| David McWilliams | M | 80 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 4 jaar |
| Donald Healey | M | 62 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 7 jaar |
| Anthony Kamin | M | 63 |
PharmaFrontiers Corp.
| - |
| Scott Gottlieb | M | 51 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | 2 jaar |
| Dawn McGuire | M | 70 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | - |
| Karthik Radhakrishnan | M | 53 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 3 jaar |
| Donna R. Rill | F | 70 |
PharmaFrontiers Corp.
| - |
| Mitzi Martinez-Montgomery | M | - |
PharmaFrontiers Corp.
| - |
| Terry H. Wesner | M | - |
PharmaFrontiers Corp.
| 1 jaar |
| Brooks Boveroux | M | - |
PharmaFrontiers Corp.
| 1 jaar |
| Jeff Randall | M | 80 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX. | 2 jaar |
| Paul Frison | M | - |
PharmaFrontiers Corp.
| - |
| Sam Whiting | M | 58 |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Gradalis, Inc. develops cancer therapies based on individuals tumor biology. The company was founded by David Shanahan and John Nemunaitis and is headquartered in Carrollton, TX. | 2 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 36 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Scott B. Seaman
- Persoonlijk netwerk